Quarterly report · Q2

Period2022-12-01 → 2023-05-31
Filed2023-07-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥4.2bn2022-12-01 → 2023-05-31Cons.Net sales
Revenue¥8.4bn2021-12-01 → 2022-11-30Cons.Net sales (5-year summary)
Revenue¥3.9bn2021-12-01 → 2022-05-31Cons.Net sales
Operating income¥156m2022-12-01 → 2023-05-31Cons.Operating income
Operating income¥226m2021-12-01 → 2022-05-31Cons.Operating income
Ordinary income¥156m2022-12-01 → 2023-05-31Cons.Ordinary income
Ordinary income¥303m2021-12-01 → 2022-11-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥235m2021-12-01 → 2022-05-31Cons.Ordinary income
Profit before tax¥155m2022-12-01 → 2023-05-31Cons.Income before income taxes
Profit before tax¥234m2021-12-01 → 2022-05-31Cons.Income before income taxes
Net income (owners)¥121m2022-12-01 → 2023-05-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥219m2021-12-01 → 2022-11-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥179m2021-12-01 → 2022-05-31Cons.Profit loss attributable to owners of parent
Net income¥121m2022-12-01 → 2023-05-31Cons.Profit loss
Net income¥179m2021-12-01 → 2022-05-31Cons.Profit loss
Total assets¥8.0bnat 2023-05-31Cons.Assets
Total assets¥8.3bnat 2022-11-30Cons.Assets
Total assets¥7.8bnat 2022-05-31Cons.Total assets (5-year summary)
Total liabilities¥5.5bnat 2023-05-31Cons.Liabilities
Total liabilities¥5.9bnat 2022-11-30Cons.Liabilities
Net assets / equity¥2.5bnat 2023-05-31Cons.Net assets
Net assets / equity¥2.4bnat 2022-11-30Cons.Net assets
Net assets / equity¥2.4bnat 2022-05-31Cons.Net assets (5-year summary)
Cash and deposits¥999mat 2023-05-31Cons.Cash and deposits
Cash and deposits¥911mat 2022-11-30Cons.Cash and deposits
Cash & equivalents¥999mat 2023-05-31Cons.Cash and cash equivalents
Cash & equivalents¥911mat 2022-11-30Cons.Cash and cash equivalents
Cash & equivalents¥984mat 2022-05-31Cons.Cash and cash equivalents
Cash & equivalents¥1.3bnat 2021-11-30dCons.Cash and cash equivalents
Operating cash flow¥223m2022-12-01 → 2023-05-31Cons.Net cash provided by used in operating activities
Operating cash flow−¥21m2021-12-01 → 2022-11-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥124m2021-12-01 → 2022-05-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥217m2022-12-01 → 2023-05-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥243m2021-12-01 → 2022-11-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥121m2021-12-01 → 2022-05-31Cons.Net cash provided by used in investment activities
Financing cash flow¥80m2022-12-01 → 2023-05-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥162m2021-12-01 → 2022-11-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥104m2021-12-01 → 2022-05-31Cons.Net cash provided by used in financing activities
EPS (basic)¥99.172022-12-01 → 2023-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥65.392023-03-01 → 2023-05-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥179.752021-12-01 → 2022-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥147.062021-12-01 → 2022-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥68.822022-03-01 → 2022-05-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio31.1%at 2023-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio29.0%at 2022-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio30.6%at 2022-05-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue2022-12-01 → 2023-05-31¥4.2bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue external2022-12-01 → 2023-05-31¥4.2bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentsegment profit2022-12-01 → 2023-05-31¥141m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue2022-12-01 → 2023-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue external2022-12-01 → 2023-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentsegment profit2022-12-01 → 2023-05-31¥15m
Total Of Reportable Segments And Otherssegment totalrevenue2022-12-01 → 2023-05-31¥4.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-12-01 → 2023-05-31¥4.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-12-01 → 2023-05-31¥156m
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue2021-12-01 → 2022-05-31¥3.9bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue external2021-12-01 → 2022-05-31¥3.9bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentsegment profit2021-12-01 → 2022-05-31¥211m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue2021-12-01 → 2022-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue external2021-12-01 → 2022-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentsegment profit2021-12-01 → 2022-05-31¥15m
Total Of Reportable Segments And Otherssegment totalrevenue2021-12-01 → 2022-05-31¥3.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-12-01 → 2022-05-31¥3.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-12-01 → 2022-05-31¥226m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 469
ItemContextValueUnit
Independent auditors report consolidated (text)FilingDateInstantText · Plus
Audit firm1 consolidatedFilingDateInstant
Original text (Japanese)海南監査法人
Cpa1 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)秋  葉   陽
Cpa2 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)古  川  雅  一
Number of submissionFilingDateInstant1
Net sales (5-year summary)Prior1YTDDuration3946010000JPY
Net sales (5-year summary)CurrentYTDDuration4206904000JPY
Net sales (5-year summary)Prior1YearDuration8368423000JPY
Ordinary income loss (5-year summary)Prior1YTDDuration235477000JPY
Ordinary income loss (5-year summary)CurrentYTDDuration156261000JPY
Ordinary income loss (5-year summary)Prior1YearDuration302812000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YTDDuration179048000JPY
Profit loss attributable to owners of parent (5-year summary)CurrentYTDDuration120732000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YearDuration218856000JPY
Comprehensive income (5-year summary)Prior1YTDDuration186936000JPY
Comprehensive income (5-year summary)CurrentYTDDuration129929000JPY
Comprehensive income (5-year summary)Prior1YearDuration219784000JPY
Net assets (5-year summary)Prior1QuarterInstant2378633000JPY
Net assets (5-year summary)CurrentQuarterInstant2480403000JPY
Net assets (5-year summary)Prior1YearInstant2411347000JPY
Total assets (5-year summary)Prior1QuarterInstant7781521000JPY
Total assets (5-year summary)CurrentQuarterInstant7970553000JPY
Total assets (5-year summary)Prior1YearInstant8321524000JPY
Basic earnings loss per share (5-year summary)Prior1YTDDuration147.06
Basic earnings loss per share (5-year summary)CurrentYTDDuration99.17
Basic earnings loss per share (5-year summary)Prior1YearDuration179.75
Diluted earnings per share (5-year summary)Prior1YTDDuration-
Diluted earnings per share (5-year summary)CurrentYTDDuration-
Diluted earnings per share (5-year summary)Prior1YearDuration-
Equity to asset ratio (5-year summary)Prior1QuarterInstant0.306
Equity to asset ratio (5-year summary)CurrentQuarterInstant0.311
Equity to asset ratio (5-year summary)Prior1YearInstant0.290
Net cash provided by used in operating activities (5-year summary)Prior1YTDDuration-124285000JPY
Net cash provided by used in operating activities (5-year summary)CurrentYTDDuration223197000JPY
Net cash provided by used in operating activities (5-year summary)Prior1YearDuration-20796000JPY
Net cash provided by used in investing activities (5-year summary)Prior1YTDDuration-120620000JPY
Net cash provided by used in investing activities (5-year summary)CurrentYTDDuration-217015000JPY
Net cash provided by used in investing activities (5-year summary)Prior1YearDuration-242937000JPY
Net cash provided by used in financing activities (5-year summary)Prior1YTDDuration-104155000JPY
Net cash provided by used in financing activities (5-year summary)CurrentYTDDuration79828000JPY
Net cash provided by used in financing activities (5-year summary)Prior1YearDuration-162168000JPY
Cash and cash equivalents (5-year summary)Prior1QuarterInstant984133000JPY
Cash and cash equivalents (5-year summary)CurrentQuarterInstant999341000JPY
Cash and cash equivalents (5-year summary)Prior1YearInstant910919000JPY
Basic earnings loss per share (5-year summary)Prior1QuarterDuration68.82
Basic earnings loss per share (5-year summary)CurrentQuarterDuration65.39
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember1220000
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember1220000
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant1220000
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant1220000

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-11-30pass
balance sheet identityconsolidated 2023-05-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-11-30pass
statement vs summary · net assetsconsolidated 2023-05-31pass
statement vs summary · net income attributable to parentconsolidated 2021-12-01/2022-05-31pass
statement vs summary · net income attributable to parentconsolidated 2022-12-01/2023-05-31pass
statement vs summary · operating cash flowconsolidated 2021-12-01/2022-05-31pass
statement vs summary · operating cash flowconsolidated 2022-12-01/2023-05-31pass
statement vs summary · revenueconsolidated 2021-12-01/2022-05-31pass
statement vs summary · revenueconsolidated 2022-12-01/2023-05-31pass
statement vs summary · total assetsconsolidated 2022-11-30pass
statement vs summary · total assetsconsolidated 2023-05-31pass